Open AccessImmune-Modulators and Thyroid Function in Oncological Patients with Hashimoto 'S Thyroiditis
Author(s) -
Matozza Francesco,
Artero Guillermo H,
Artero Guillermo,
Levy Daniel,
Carvallo Héctor
Publication year - 2021
Publication title -
cancer science and research
Language(s) - English
Resource type - Journals
ISSN - 2639-8478
DOI - 10.33425/2639-8478.1067
Subject(s) - thyroiditis , medicine , immune system , autoantibody , hashimoto disease , thyroid , thyroid function , immunology , autoimmunity , antibody
Hashimoto's thyroiditis (HT) is a form of chronic lymphocytic thyoriditis, of autoimmune origin and multiple physiopathogenic pathways, which may or may not be associated with other autoantibody diseases, both endocrinological (P.A.S.) and non-endocrinological (M.A.S.). Likewise, HT can coincide -in the same patient- with very varied oncological pathologies, with which it can interact in a usually negative way. In this article, the benefit achieved in cancer patients who also had HT is evaluated through the use of immune-modulators.